Sylvester Comments on Legal Uncertainty Surrounding CBD-Infused Products
10 December 2019
Special Counsel Brian Sylvester was quoted in a Food Navigator-USA article, “Attorneys weigh in on CBD lawsuits: ‘A wave of class action litigation was almost inevitable,’” about the legal uncertainty surrounding cannabidiol-infused products.
Sylvester noted that the FDA had said in a recent announcement that it would provide an update on the regulatory path forward in the coming weeks. “Because FDA is actively exploring a possible lawful regulatory pathway for adding CBD to foods and dietary supplements, it is not inconceivable that certain courts would be amenable to staying proceedings to allow the FDA time to develop guidance or new rules to facilitate the lawful marketing of CBD-infused foods and dietary supplements,” he said.
Related News
26 March 2024
In the News
Foley Made ‘Great Strides’ in 2023 as Firm Sees Record Revenue and Profits
In the article, “Diversity of Practices Helped Foley Grow Revenue by 8.1%, Profits Per Equity Partner by 11.5%” The American Lawyer notes that strong demand across each of Foley’s major strategic sectors – including energy, health care and life sciences, innovative technology, and manufacturing – led to record growth.
22 March 2024
In the News
Foley LA Prepares Boys & Girls Clubs Students for Youth of the Year Competition
Foley & Lardner LLP partner Nicholas Gross and associates Trevor Mullin, Kathryn Petrosky, Jordan Smiley, Savannah Levin, Troy Tessem, and Tam Wheat helped prepare students from the Boys & Girls Clubs of Metro Los Angeles for the annual Youth of the Year competition.
22 March 2024
In the News
Kyle Faget Quoted on FDA’s Approach to AI in Digital Health
Foley & Lardner LLP partner Kyle Faget is quoted in the Modern Healthcare article, “FDA is digital health’s gatekeeper amid AI boom.”